Agilent Technologies, Inc. (NYSE:A) Shares Sold by Fulton Bank N.A.

Fulton Bank N.A. lowered its position in Agilent Technologies, Inc. (NYSE:A) by 2.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,624 shares of the medical research company’s stock after selling 283 shares during the quarter. Fulton Bank N.A.’s holdings in Agilent Technologies were worth $1,429,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. Crewe Advisors LLC increased its position in shares of Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares during the last quarter. Livelsberger Financial Advisory acquired a new stake in shares of Agilent Technologies during the fourth quarter valued at about $26,000. Ridgewood Investments LLC purchased a new stake in shares of Agilent Technologies in the 2nd quarter valued at approximately $29,000. Rise Advisors LLC lifted its holdings in shares of Agilent Technologies by 527.8% in the 1st quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after acquiring an additional 190 shares during the last quarter. Finally, YHB Investment Advisors Inc. purchased a new position in shares of Agilent Technologies during the 1st quarter worth approximately $34,000. 87.42% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the sale, the chief executive officer now owns 24,118 shares of the company’s stock, valued at $3,497,110. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,953 shares of company stock valued at $2,013,630. 0.33% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on A. Bank of America boosted their target price on Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. UBS Group lifted their target price on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. Citigroup increased their price target on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. TD Cowen lifted their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Finally, Wolfe Research lowered shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a report on Thursday, June 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $143.64.

Agilent Technologies Price Performance

Shares of A opened at $143.89 on Tuesday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. Agilent Technologies, Inc. has a 1-year low of $96.80 and a 1-year high of $155.35. The stock has a market cap of $41.98 billion, a PE ratio of 34.02, a price-to-earnings-growth ratio of 6.48 and a beta of 1.05. The firm has a fifty day moving average price of $140.12 and a 200 day moving average price of $138.97.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The company’s revenue for the quarter was down 5.6% compared to the same quarter last year. During the same period last year, the firm posted $1.43 earnings per share. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st will be paid a dividend of $0.236 per share. This represents a $0.94 annualized dividend and a yield of 0.66%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio is presently 22.22%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.